ReproNovo has appointed Mark Altmeyer as Chairman of the Board of Directors. Bringing over 35 years of experience to the role ...

Stop losing momentum to the "logistics lag." The most successful life science teams have moved beyond fragmented spreadsheets ...

Novartis is to acquire Excellergy, a private biotech company developing next-generation anti-IgE therapies for IgE-driven ...

Novo Nordisk’s Awiqli (insulin icodec) has been approved by the US FDA as the first and only once-weekly, long-acting basal ...

Roche has opened a new research facility for the Institute of Human Biology (IHB) in Basel, Switzerland. The building will ...

Sandoz has partnered with Samsung Bioepis to broaden patient access to high-quality biosimilar medicines worldwide. The ...

With unprecedented patent cliffs looming, putting an estimated $200 to $400 billion in annual global sales at risk , senior ...

Poolbeg Pharma, a clinical-stage biopharmaceutical company focused on cancer immunotherapy, has appointed Adrian Kilcoyne to ...

The digital age and the advance of AI have created a temptation to push communications to the furthest realms of personalisation, but that quest could also lure campaigns to the dark side of the moon ...

Pharma does not have a content shortage. It has a content architecture problem. Over the last decade, our industry has ...

Opdivo (nivolumab) has been approved for two new classical Hodgkin lymphoma (cHL) indications in the US and the EU. The US ...

The Public Relations Global Network (PRGN) has announced that OVID Health, an independent public relations and public affairs ...